BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 27206718)

  • 1. Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.
    Vogt Weisenhorn DM; Giesert F; Wurst W
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):8-26. PubMed ID: 27206718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.
    Anderegg A; Poulin JF; Awatramani R
    FEBS Lett; 2015 Dec; 589(24 Pt A):3714-26. PubMed ID: 26505674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
    Kastner A; Hirsch EC; Herrero MT; Javoy-Agid F; Agid Y
    J Neurochem; 1993 Sep; 61(3):1024-34. PubMed ID: 8103078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures But Not After Intrastriatal Transplantation in a Rat Model of Parkinson's Disease.
    Di Santo S; Seiler S; Ducray AD; Meyer M; Widmer HR
    Cell Transplant; 2017 Apr; 26(4):679-691. PubMed ID: 27938488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of midbrain dopaminergic neuron development.
    Blaess S; Ang SL
    Wiley Interdiscip Rev Dev Biol; 2015; 4(2):113-34. PubMed ID: 25565353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
    Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
    J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing.
    Fiorenzano A; Sozzi E; Parmar M; Storm P
    Cells; 2021 Jun; 10(6):. PubMed ID: 34206038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
    Luk KC; Rymar VV; van den Munckhof P; Nicolau S; Steriade C; Bifsha P; Drouin J; Sadikot AF
    J Neurochem; 2013 Jun; 125(6):932-43. PubMed ID: 23331067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.
    Decressac M; Volakakis N; Björklund A; Perlmann T
    Nat Rev Neurol; 2013 Nov; 9(11):629-36. PubMed ID: 24126627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration.
    Gómez-López S; Martínez-Silva AV; Montiel T; Osorio-Gómez D; Bermúdez-Rattoni F; Massieu L; Escalante-Alcalde D
    Sci Rep; 2016 Apr; 6():24028. PubMed ID: 27063549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of FBXO7 results in a Parkinson's-like dopaminergic degeneration via an RPL23-MDM2-TP53 pathway.
    Stott SR; Randle SJ; Al Rawi S; Rowicka PA; Harris R; Mason B; Xia J; Dalley JW; Barker RA; Laman H
    J Pathol; 2019 Oct; 249(2):241-254. PubMed ID: 31144295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson's Disease.
    Samson JS; Ramesh A; Parvathi VD
    Neuroscience; 2024 May; 546():1-19. PubMed ID: 38522661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
    Mouatt-Prigent A; Karlsson JO; Agid Y; Hirsch EC
    Neuroscience; 1996 Aug; 73(4):979-87. PubMed ID: 8809817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
    Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration.
    Volpicelli F; Perrone-Capano C; Bellenchi GC; Colucci-D'Amato L; di Porzio U
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules.
    Grison A; Zucchelli S; Urzì A; Zamparo I; Lazarevic D; Pascarella G; Roncaglia P; Giorgetti A; Garcia-Esparcia P; Vlachouli C; Simone R; Persichetti F; Forrest AR; Hayashizaki Y; Carloni P; Ferrer I; Lodovichi C; Plessy C; ; Carninci P; Gustincich S
    BMC Genomics; 2014 Aug; 15(1):729. PubMed ID: 25164183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.